$RGDX Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$RGDX Up to date company activities and other important information about $RGDX

$RGDX

DD Notes ~ http://www.ddnotesmaker.com/RGDX

##### recent news/filings ~ source: finance.yahoo.com

Fri, 13 Dec 2013 22:11:39 GMT ~ RESPONSE GENETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stateme
read full: http://biz.yahoo.com/e/131213/rgdx8-k.html
*********************************************************

Fri, 13 Dec 2013 15:35:26 GMT ~ Response Genetics, Inc. Announces Pricing of Underwritten Public Offering
- LOS ANGELES, Dec. 13, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX) (the "Company"), a company focused on the development and sale of molecular diagnostic tests that help determine ...
read full: http://www.noodls.com/view/7BF783BA425A4AFA0F0B9D3159D33F1DBA58D0EF
*********************************************************

Fri, 13 Dec 2013 14:03:22 GMT ~ Response Genetics 4.46M share Secondary priced at $1.20
read full: http://www.theflyonthewall.com/permalinks/entry.php/RGDXid1933714/RGDX-Response-Genetics-M-share-Secondary-priced-at-
*********************************************************

Fri, 13 Dec 2013 14:00:00 GMT ~ Response Genetics, Inc. Announces Pricing of Underwritten Public Offering
- LOS ANGELES -- Response Genetics, Inc. (the "Company"), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, ...
read full: http://finance.yahoo.com/news/response-genetics-inc-announces-pricing-140000847.html
*********************************************************

Thu, 12 Dec 2013 22:59:10 GMT ~ Response Genetics, Inc. Announces Proposed Underwritten Public Offering
- LOS ANGELES, Dec. 12, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX) (the "Company"), a company focused on the development and sale of molecular diagnostic tests that help determine ...
read full: http://www.noodls.com/view/819576ABA88E7D966B41A7513523846CDF262E23
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=RGDX&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=RGDX&w=700&h=600&t=1&bs=candle&ma=50-200&mat=SMA-SMA&i=MACD&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/RGDX/company-info
Ticker: $RGDX
OTC Market Place: Not Available
CIK code: 0001124608
Company name: Response Genetics, Inc.
Company website: http://www.responsegenetics.com
Incorporated In: DE, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001124608&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/RGDX/filings
Latest financials: http://www.otcmarkets.com/stock/RGDX/financials
Latest news: http://www.otcmarkets.com/stock/RGDX/news - http://finance.yahoo.com/q/h?s=RGDX+Headlines

Major holdings: http://data.cnbc.com/quotes/RGDX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=RGDX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/RGDX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=RGDX

RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=RGDX&search=search

DTCC: http://search2.dtcc.com/?q=Response+Genetics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Response+Genetics%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Response+Genetics%2C+Inc.&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.responsegenetics.com
Alexa: http://www.alexa.com/siteinfo/http://www.responsegenetics.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.responsegenetics.com

http://www.pennystocktweets.com/stocks/profile/RGDX

##### last known share structure ~ source: otcmarkets.com

Market Value: $71,236,782 a/o Dec 16, 2013
Shares Outstanding: 34,248,453 a/o Nov 12, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

##### business description ~ source: otcmarkets.com

Response Genetics, Inc. is engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies which enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin embedded specimens.

DD Notes ~ http://www.ddnotesmaker.com/RGDX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iCapital Enhances Portfolio Solutions For Global Investors

Updated Category News Views 267

iCapital Enhances Portfolio Construction Tools for Investors iCapital, a leading global fintech platform, has introduced significant enhancements to its innovative portfolio construction tool, iCapital Architect. This advanced platform is designed to simplify the integration of alternative investments into traditional portfolio strategies. Financial advisors gain access...

Continue Reading
Market Adaptability: S&P 500 Faces Correction Ahead

Updated Category News Views 210

Understanding Recent Market Movements The market experienced a turbulent session recently, sending investors into a state of caution. This volatility was significantly influenced by renewed discussions around tariffs impacting trade relationships, particularly involving technology and manufacturing sectors. The Impact of Tariffs on the Market Former President Trump's...

Continue Reading
Performance Systems Integration Merges with Summit Fire & Security

Updated Category News Views 177

Performance Systems Integration Merger with Summit Fire & Security Performance Systems Integration (PSI), recognized as the leading fire and life safety solutions provider in the Pacific Northwest, has completed a merger with Summit Fire & Security LLC, which is a subsidiary of SFP Holding, Inc. This merger marks a significant collaboration that aims to enhance the safety...

Continue Reading
Candel Therapeutics Shares Optimistic Findings on CAN-3110

Updated Category News Views 159

Revealing Interim Results from Candel Therapeutics NEEDHAM, Mass. — Candel Therapeutics, Inc. (Nasdaq: CADL), a biopharmaceutical company dedicated to advancing biological immunotherapies to combat cancer, has announced noteworthy interim data stemming from its ongoing phase 1b clinical trial of CAN-3110 (linoserpaturev) targeting recurrent glioblastoma. This...

Continue Reading
Supernus Pharmaceuticals Reaches New Heights with Strong Growth

Updated Category News Views 83

Supernus Pharmaceuticals Hits Record Stock Levels Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has achieved a remarkable milestone, as its stock recently surged to a 52-week high of $35.45. This significant increase showcases the company’s strong financial performance and growth prospects, creating a wave of optimism among investors. The stock has risen an impressive...

Continue Reading